pathway,nums,percent,pvalue,,
Spliceosome,98,96.08,0,,
DNA replication,33,100,0,,
Ribosome biogenesis in eukaryotes,52,92.86,0,,
Ribosome,88,88,0,,
"Ribosome, eukaryotes",63,95.45,0,,
"Spliceosome, U4/U6.U5 tri-snRNP",18,85.71,0,,
RNA polymerase,18,81.82,0,,
Mismatch repair,22,100,0,,
RNA transport,111,96.52,0,,
Base excision repair,30,90.91,0,,
"Spliceosome, U2-snRNP",18,94.74,0,,
Nuclear pore complex,25,83.33,0,,
Polycomb repressive complex,61,96.83,0,,
mRNA surveillance pathway,61,91.04,0,,
Coronavirus disease - COVID-19,100,85.47,0,,
"Spliceosome, 35S U5-snRNP",22,84.62,0,,
Homologous recombination,29,93.55,0,,
Nucleocytoplasmic transport,79,95.18,0,,
BRCA1-associated genome surveillance complex (BASC),15,100,0,,
Fanconi anemia pathway,28,87.5,0.0001,,
Cell cycle,129,99.23,0.0001,,
RNA degradation,39,84.78,0.0001,,
"RNA polymerase II, eukaryotes",6,100,0.0002,,
"Spliceosome, U1-snRNP",8,88.89,0.0003,,
Nucleotide excision repair,37,88.1,0.0005,,
"RNA polymerase I, eukaryotes",7,100,0.0007,,
Herpes simplex infection,88,93.62,0.0008,,
Cytochrome bc1 complex,7,100,0.0009,,
Sm core complex,7,100,0.001,,
MCM complex,6,100,0.0011,,
"RNA polymerase III, eukaryotes",10,90.91,0.0015,,
Basal transcription factors,35,89.74,0.0026,,
Proteasome,21,70,0.0049,,
Exon junction complex (EJC),16,100,0.0048,,
RF-C complex,5,100,0.0068,,
Pyrimidine metabolism,66,92.96,0.0135,,
"Exosome, eukaryotes",6,100,0.0139,,
"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",6,100,0.0151,,
"Aminoacyl-tRNA biosynthesis, eukaryotes",18,72,0.0189,,
FA core complex,6,100,0.0195,,
DNA damage-induced cell cycle checkpoints,7,100,0.0194,,
Cell cycle - G2/M transition,7,100,0.0209,,
THC complex,5,100,0.0284,,
Aminoacyl-tRNA biosynthesis,22,75.86,0.0304,,
Systemic lupus erythematosus,8,66.67,0.0365,,
Amyotrophic lateral sclerosis,155,80.31,0.0423,,
Purine metabolism,91,94.79,0.0507,,
Non-homologous end-joining,6,100,0.0575,,
Huntington's disease,72,66.67,0.0673,,
"Spliceosome, Prp19/CDC5L complex",8,100,0.0668,,
Oocyte meiosis,64,82.05,0.0715,,
Glycolysis / Gluconeogenesis,15,48.39,0.086,,
"Proteasome, 19S regulatory particle (PA700)",6,50,0.09,,
"Proteasome, 20S core particle",9,100,0.1077,,
Parkinson's disease,32,42.67,0.1101,,
Cytosolic DNA-sensing pathway,27,84.38,0.1108,,
Nitrogen metabolism,5,83.33,0.1384,,
Shelterin complex,5,100,0.1381,,
One carbon pool by folate,11,84.62,0.1443,,
2-Oxocarboxylic acid metabolism,20,100,0.142,,
"Alanine, aspartate and glutamate metabolism",11,47.83,0.1402,,
"Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate",6,100,0.1409,,
Sulfur metabolism,3,33.33,0.1635,,
Methionine salvage pathway,4,80,0.1815,,
Arginine and proline metabolism,13,48.15,0.1797,,
"F-type ATPase, eukaryotes",2,33.33,0.1936,,
Staphylococcus aureus infection,12,85.71,0.2152,,
Antifolate resistance,12,80,0.2128,,
TREX complex,8,100,0.2451,,
Thyroid cancer,12,57.14,0.242,,
Phenylalanine metabolism,10,100,0.2603,,
Viral life cycle - HIV-1,26,76.47,0.2638,,
beta-Alanine metabolism,6,31.58,0.2853,,
Drug metabolism - cytochrome P450,8,34.78,0.2857,,
Progesterone-mediated oocyte maturation,55,82.09,0.2906,,
Citrate cycle (TCA cycle),21,100,0.2996,,
Immunoproteasome,14,100,0.3098,,
Tyrosine metabolism,17,100,0.3183,,
Transcriptional misregulation in cancer,86,93.48,0.3276,,
Chemical carcinogenesis - reactive oxygen species,57,46.72,0.3285,,
Glyoxylate and dicarboxylate metabolism,12,60,0.3272,,
Cysteine and methionine metabolism,23,82.14,0.3294,,
Methionine degradation,4,66.67,0.3384,,
Holo-TFIIH complex,10,100,0.3608,,
Origin recognition complex,6,100,0.3641,,
Glycerolipid metabolism,15,60,0.3711,,
eIF4F complex,7,100,0.3689,,
Huntington disease,120,74.53,0.3728,,
NOD-like receptor signaling pathway,52,54.74,0.3721,,
Triacylglycerol biosynthesis,9,100,0.3838,,
"Citrate cycle (TCA cycle, Krebs cycle)",17,100,0.3892,,
IL-17 signaling pathway,27,67.5,0.3942,,
Chemical carcinogenesis - receptor activation,67,65.69,0.4018,,
Bladder cancer,16,66.67,0.4211,,
Platinum drug resistance,41,70.69,0.4211,,
Parkinson disease,84,59.15,0.4313,,
Retinol metabolism,6,60,0.4286,,
Survival motor neuron (SMN) complex,8,100,0.4637,,
Prostate cancer,55,91.67,0.4921,,
Primary immunodeficiency,5,71.43,0.4887,,
Inositol phosphate metabolism,22,47.83,0.5127,,
Prion diseases,10,47.62,0.5455,,
"NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria",8,100,0.5403,,
Endometrial cancer,23,67.65,0.5674,,
Notch signaling pathway,19,57.58,0.5806,,
BER complex,8,100,0.5791,,
Lipoic acid metabolism,11,100,0.5827,,
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,6,100,0.5775,,
Drug metabolism - other enzymes,31,77.5,0.5842,,
African trypanosomiasis,9,64.29,0.5853,,
Th17 cell differentiation,34,69.39,0.5974,,
"Leucine degradation, leucine => acetoacetate + acetyl-CoA",9,100,0.6075,,
"C1-unit interconversion, eukaryotes",6,100,0.6122,,
Amyotrophic lateral sclerosis (ALS),18,58.06,0.6411,,
Fluid shear stress and atherosclerosis,42,50.6,0.6394,,
Glutathione metabolism,28,70,0.6368,,
Oxidative phosphorylation,29,42.03,0.6379,,
Signaling pathways regulating pluripotency of stem cells,61,77.22,0.6356,,
Breast cancer,57,79.17,0.6383,,
Selenocompound metabolism,11,100,0.6487,,
RIG-I-like receptor signaling pathway,21,67.74,0.6443,,
Mitophagy - animal,18,41.86,0.6461,,
Carbon metabolism,41,60.29,0.6715,,
Legionellosis,17,70.83,0.6784,,
Antigen processing and presentation,17,70.83,0.6758,,
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex,11,100,0.6792,,
"Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate",11,100,0.6836,,
NF-kappa B signaling pathway,37,69.81,0.7308,,
"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate",11,100,0.7359,,
Activin signaling,6,100,0.7519,,
Folate biosynthesis,5,45.45,0.7664,,
Thermogenesis,74,63.25,0.776,,
Phosphatidylinositol signaling system,26,45.61,0.7718,,
Nucleotide metabolism,40,85.11,0.7667,,
Lipid and atherosclerosis,70,70.71,0.7671,,
Central carbon metabolism in cancer,21,50,0.7746,,
Hepatocellular carcinoma,84,83.17,0.7752,,
Biosynthesis of amino acids,27,64.29,0.797,,
Spinocerebellar ataxia,56,69.14,0.8208,,
"Glycine, serine and threonine metabolism",15,75,0.8196,,
Metabolic pathways,536,92.57,0.8236,,
Colorectal cancer,37,66.07,0.8237,,
Thyroid hormone signaling pathway,55,75.34,0.8233,,
Mucin type O-glycan biosynthesis,4,33.33,0.8287,,
"O-glycan biosynthesis, mucin type core",4,40,0.8428,,
Cell cycle - G1/S transition,11,91.67,0.8721,,
Gastric cancer,57,79.17,0.8742,,
Hepatitis C,74,90.24,0.9304,,
Acute myeloid leukemia,29,72.5,0.9278,,
Pyruvate metabolism,16,55.17,0.9297,,
Longevity regulating pathway - multiple species,16,41.03,0.9251,,
Fructose and mannose metabolism,18,100,0.9392,,
Arachidonic acid metabolism,9,39.13,0.9611,,
Neuroactive ligand-receptor interaction,19,39.58,0.9774,,
Metabolism of xenobiotics by cytochrome P450,10,38.46,0.9904,,
HTLV-I infection,144,96,0.9847,,
Peroxisome,10,25,0.9843,,
Basal cell carcinoma,17,70.83,0.9956,,
Cell adhesion molecules,28,63.64,0.9929,,
Cell adhesion molecules (CAMs),27,65.85,0.9868,,
ATP-dependent chromatin remodeling,64,92.75,0.9943,,
Cytochrome c oxidase,14,100,0.9955,,
Chronic myeloid leukemia,47,87.04,0.9895,,
Histidine metabolism,11,100,0.993,,
Herpes simplex virus 1 infection,134,88.74,0.9878,,
Estrogen signaling pathway,45,70.31,0.9881,,
APC/C complex,12,100,0.9836,,
Hippo signaling,5,41.67,0.9901,,
Hippo signaling pathway - multiple species,5,29.41,0.9854,,
Type II diabetes mellitus,7,38.89,0.9802,,
Fat digestion and absorption,12,100,0.9779,,
Arginine biosynthesis,9,100,0.9795,,
Hippo signaling pathway -multiple species,5,29.41,0.9754,,
Ubiquitin mediated proteolysis,71,80.68,0.9722,,
ECM-receptor interaction,10,23.26,0.9691,,
Glucagon signaling pathway,38,74.51,0.9661,,
N-glycan precursor biosynthesis,4,57.14,0.9693,,
ErbB signaling pathway,22,43.14,0.9657,,
Biosynthesis of cofactors,49,68.06,0.9653,,
Thiamine metabolism,7,100,0.9809,,
Ubiquinone and other terpenoid-quinone biosynthesis,3,60,0.9755,,
BMP signaling,5,45.45,0.9713,,
Proximal tubule bicarbonate reclamation,14,100,0.9697,,
Leishmaniasis,17,53.12,0.9644,,
Protein processing in endoplasmic reticulum,50,55.56,0.9649,,
Biosynthesis of nucleotide sugars,7,31.82,0.9961,,
Jak-STAT signaling pathway,33,57.89,1,,
JAK-STAT signaling pathway,33,55,0.9961,,
"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA",1,20,NA,,
MAPK (JNK) signaling,1,11.11,NA,,
MAPK (p38) signaling,1,8.33,NA,,
